|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1996-1-16
|
|
pubmed:abstractText |
We assessed compliance, relief of climacteric symptoms, and impact on lumbar bone mineral density in two groups of 140 patients treated with a sequential estrogen-progestogen or a continuous combined replacement therapy in comparison with controls.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
173
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1446-51
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:7503183-Analysis of Variance,
pubmed-meshheading:7503183-Bone Density,
pubmed-meshheading:7503183-Climacteric,
pubmed-meshheading:7503183-Drug Administration Schedule,
pubmed-meshheading:7503183-Estradiol,
pubmed-meshheading:7503183-Estriol,
pubmed-meshheading:7503183-Estrogen Replacement Therapy,
pubmed-meshheading:7503183-Female,
pubmed-meshheading:7503183-Follicle Stimulating Hormone,
pubmed-meshheading:7503183-Follow-Up Studies,
pubmed-meshheading:7503183-Humans,
pubmed-meshheading:7503183-Medroxyprogesterone Acetate,
pubmed-meshheading:7503183-Middle Aged,
pubmed-meshheading:7503183-Norethindrone,
pubmed-meshheading:7503183-Patient Compliance,
pubmed-meshheading:7503183-Sex Hormone-Binding Globulin,
pubmed-meshheading:7503183-Time Factors
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Westfälische Wilhelms-Universität, Münster, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
